Quintás-Cardama, A., Kantarjian, H., O’Brien, S., Jabbour, E., Borthakur, G., Ravandi, F., . . . Cortes, J. (2011). Outcome of patients with chronic myeloid leukemia with multiple ABL1 kinase domain mutations receiving tyrosine kinase inhibitor therapy. Ferrata Storti Foundation.

Quintás-Cardama, Alfonso, Hagop Kantarjian, Susan O’Brien, Elias Jabbour, Gautam Borthakur, Farhad Ravandi, Srdan Verstovsek, Jianqin Shan, und Jorge Cortes. Outcome of Patients With Chronic Myeloid Leukemia With Multiple ABL1 Kinase Domain Mutations Receiving Tyrosine Kinase Inhibitor Therapy. Ferrata Storti Foundation, 2011.

Quintás-Cardama, Alfonso, et al. Outcome of Patients With Chronic Myeloid Leukemia With Multiple ABL1 Kinase Domain Mutations Receiving Tyrosine Kinase Inhibitor Therapy. Ferrata Storti Foundation, 2011.